Daniel L. Alkon - Jun 14, 2021 Form 4 Insider Report for Synaptogenix, Inc. (SNPX)

Role
Chief Scientific Officer, Director
Signature
/s/ Robert Weinstein, Attorney-in-fact
Stock symbol
SNPX
Transactions as of
Jun 14, 2021
Transactions value $
$82,600
Form type
4
Date filed
6/16/2021, 01:01 PM
Previous filing
Jun 14, 2021
Next filing
Dec 1, 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SNPX Common Stock, par value $0.0001 per share Purchase $82.6K +10K +673.85% $8.26* 11.5K Jun 14, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $8.19 to $8.35, inclusive. The reporting person undertakes to provide to Synaptogenix, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney